Description
Title: An Indian perspective on the development of mesenchymal stem cell therapy as an advanced therapeutic medicine (ATMP)
Abstract: The cells that have the ability to self-renew and give rise to differentiated cells are known as stem cells. Depending on their source and bio-plasticity, stem cells can differentiate into multiple cell lineages and grow into a variety of mature tissues under the right circumstances and signals. cells. One rapidly evolving area of medicine is stem cell therapy, which includes the most cutting-edge regenerative treatments for restoring cell and tissue function in patients with severe diseases. Cell-based therapies for conditions that are resistant to conventional treatments and medications have emerged as a result of stem cell research, and they are classified as advanced therapeutic medicinal products (ATMP). In 2017, the FDA and the European Medicines Agency (EMA) developed a new strategy with the goal of harmonizing the standards for the development of ATMPs so that information can be exchanged easily on a global scale. In this evaluation, we go over the The development of mesenchymal stem cell-based therapy as an ATMP in the international and Indian contexts, as well as the rules governing their application in clinical settings, are discussed.
Keywords: ATMP; India; stem cell; mesenchymal stem cell; regulations
Paper Quality: SCOPUS / Web of Science Level Research Paper
Subject: Bioengineering
Writer Experience: 20+ Years
Plagiarism Report: Turnitin Plagiarism Report will be less than 10%
Restriction: Only one author may purchase a single paper. The paper will then indicate that it is out of stock.
What will I get after the purchase?
A turnitin plagiarism report of less than 10% in a pdf file and a full research paper in a word document.
In case you have any questions related to this research paper, please feel free to call/ WhatsApp on +919726999915
Reviews
There are no reviews yet.